Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 18, 2023 | Post-IPO Equity | $113.55M | — | — | — | Detail |
Sep 8, 2021 | Post-IPO Equity | $75M | — | — | — | Detail |
Jun 14, 2019 | IPO | — | — | — | — | Detail |
Dec 7, 2016 | Post-IPO Equity | $250M | — | — | — | Detail |
Oct 27, 2012 | Series Unknown | $9.30M | 1 | California Institute for Regenerative Medicine | — | Detail |
Jul 25, 2012 | Series D | $60M | 7 | — | — | Detail |
Apr 20, 2011 | Series C | $30M | 5 | ARCH Venture Partners | — | Detail |
Mar 16, 2011 | Grant | $4.20M | — | — | — | Detail |
Mar 12, 2010 | Series B | $35M | 5 | Sanofi Ventures , Third Rock Ventures | — | Detail |
Oct 7, 2004 | Series Unknown | $12M | 3 | Techno Venture Management | — | Detail |
Jun 17, 2004 | Series A | $8.50M | 2 | — | — | Detail |